chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Heart rate increased, Pain, Pain in extremity, Peripheral swelling, Pyrexia
Clinical narrative: Heart rate increased; Weakness; Ache; Pain in arm; Redness; Swelling arm; Dizziness; Chills; Throat tightness; Fever; Headache; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever), HEART RATE INCREASED (Heart rate increased), HEADACHE (Headache), ASTHENIA (Weakness) and PAIN (Ache) in an 80-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031LZ0A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 (Tested positive for antibodies in November 2020. Waited 90 days before receiving the vaccine. ) in October 2020. Concurrent medical conditions included Shellfish allergy.    On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PYREXIA (Fever), HEART RATE INCREASED (Heart rate increased), HEADACHE (Headache), ASTHENIA (Weakness), PAIN (Ache), PAIN IN EXTREMITY (Pain in arm), ERYTHEMA (Redness), PERIPHERAL SWELLING (Swelling arm), DIZZINESS (Dizziness), CHILLS (Chills) and THROAT TIGHTNESS (Throat tightness). The patient was treated with DIPHENHYDRAMINE, PARACETAMOL (EXTRA STRENGTH TYLENOL PM) at a dose of UNK dosage form. At the time of the report, PYREXIA (Fever), HEART RATE INCREASED (Heart rate increased), HEADACHE (Headache), ASTHENIA (Weakness), PAIN (Ache), PAIN IN EXTREMITY (Pain in arm), ERYTHEMA (Redness), PERIPHERAL SWELLING (Swelling arm), DIZZINESS (Dizziness), CHILLS (Chills) and THROAT TIGHTNESS (Throat tightness) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In November 2020, SARS-CoV-2 antibody test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 antibody test, Throat tightness
Clinical narrative: Heart rate increased; Weakness; Ache; Pain in arm; Redness; Swelling arm; Dizziness; Chills; Throat tightness; Fever; Headache; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever), HEART RATE INCREASED (Heart rate increased), HEADACHE (Headache), ASTHENIA (Weakness) and PAIN (Ache) in an 80-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031LZ0A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 (Tested positive for antibodies in November 2020. Waited 90 days before receiving the vaccine. ) in October 2020. Concurrent medical conditions included Shellfish allergy.    On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PYREXIA (Fever), HEART RATE INCREASED (Heart rate increased), HEADACHE (Headache), ASTHENIA (Weakness), PAIN (Ache), PAIN IN EXTREMITY (Pain in arm), ERYTHEMA (Redness), PERIPHERAL SWELLING (Swelling arm), DIZZINESS (Dizziness), CHILLS (Chills) and THROAT TIGHTNESS (Throat tightness). The patient was treated with DIPHENHYDRAMINE, PARACETAMOL (EXTRA STRENGTH TYLENOL PM) at a dose of UNK dosage form. At the time of the report, PYREXIA (Fever), HEART RATE INCREASED (Heart rate increased), HEADACHE (Headache), ASTHENIA (Weakness), PAIN (Ache), PAIN IN EXTREMITY (Pain in arm), ERYTHEMA (Redness), PERIPHERAL SWELLING (Swelling arm), DIZZINESS (Dizziness), CHILLS (Chills) and THROAT TIGHTNESS (Throat tightness) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In November 2020, SARS-CoV-2 antibody test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site rash
Clinical narrative: Red rash around where the injection site; Red rash around where the injection site; A little painful; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (Red rash around where the injection site), VACCINATION SITE ERYTHEMA (Red rash around where the injection site) and VACCINATION SITE PAIN (A little painful) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination.     Concurrent medical conditions included Allergy (The patient takes nasal spray for allergy). Concomitant products included GABAPENTIN, LEVOTHYROXINE SODIUM (SYNTHROID), VITAMIN D3 and KALLIDINOGENASE (SOMAX) for an unknown indication.    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, the patient experienced VACCINATION SITE RASH (Red rash around where the injection site), VACCINATION SITE ERYTHEMA (Red rash around where the injection site) and VACCINATION SITE PAIN (A little painful). At the time of the report, VACCINATION SITE RASH (Red rash around where the injection site), VACCINATION SITE ERYTHEMA (Red rash around where the injection site) and VACCINATION SITE PAIN (A little painful) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The concomitant medication also included antidepressants, nasal spray for allergy.   Treatment medications were not provided.   This case was linked to MOD-2021-082190 (E2B Linked Report).; Sender's Comments:  MOD-2021-082190:Same patient (2nd dose)
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Urticaria
Clinical narrative: Redness; Wheals; This spontaneous case was reported by a consumer and describes the occurrence of   in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) and mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site discolouration, Injection site erythema, Injection site swelling, Type IV hypersensitivity reaction
Clinical narrative: generalized pink discoloration near the injection site; covid arm; lump near the injection site; red patch on the injection upper arm; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE DISCOLOURATION (generalized pink discoloration near the injection site), TYPE IV HYPERSENSITIVITY REACTION (covid arm), INJECTION SITE SWELLING (lump near the injection site) and INJECTION SITE ERYTHEMA (red patch on the injection upper arm) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (NO historical condition reported.).   On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 2 dosage form. On 28-Jan-2021, the patient experienced INJECTION SITE ERYTHEMA (red patch on the injection upper arm). On 31-Jan-2021, the patient experienced INJECTION SITE DISCOLOURATION (generalized pink discoloration near the injection site), TYPE IV HYPERSENSITIVITY REACTION (covid arm) and INJECTION SITE SWELLING (lump near the injection site). At the time of the report, INJECTION SITE DISCOLOURATION (generalized pink discoloration near the injection site), TYPE IV HYPERSENSITIVITY REACTION (covid arm), INJECTION SITE SWELLING (lump near the injection site) and INJECTION SITE ERYTHEMA (red patch on the injection upper arm) outcome was unknown. Related          Treatment details included Patient used Ice to treat the delayed injection site reaction. No relevant concomitant medications were reported For mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route), the reporter did not provide any causality assessments. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) was not applicable
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling, Vaccination site warmth
Clinical narrative: Hot at injection site; Red at injection site; Swollen at injection site; Itchy at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Hot at injection site), VACCINATION SITE ERYTHEMA (Red at injection site), VACCINATION SITE SWELLING (Swollen at injection site) and VACCINATION SITE PRURITUS (Itchy at injection site) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included FISH OIL, TURMERIC [CURCUMA LONGA RHIZOME], CUCURBITA PEPO SEED OIL, LYCOPENE, OENOTHERA BIENNIS OIL, SELENIUM, SERENOA REPENS, ZINC (SAW PALMETTO COMPLETE), CALCIUM, COLECALCIFEROL (VITAMIN D 3) and METHYLSULFONYLMETHANE (MSM COMPLETE) for an unknown indication.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Feb-2021, the patient experienced VACCINATION SITE WARMTH (Hot at injection site), VACCINATION SITE ERYTHEMA (Red at injection site), VACCINATION SITE SWELLING (Swollen at injection site) and VACCINATION SITE PRURITUS (Itchy at injection site). At the time of the report, VACCINATION SITE WARMTH (Hot at injection site), VACCINATION SITE ERYTHEMA (Red at injection site), VACCINATION SITE SWELLING (Swollen at injection site) and VACCINATION SITE PRURITUS (Itchy at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Headache, Myalgia, Nausea
Clinical narrative: Vomiting; Body ache; Fever; Chills; Nausea; Headache; Joint pain; This spontaneous case was reported by a nurse and describes the occurrence of VOMITING (Vomiting), MYALGIA (Body ache), PYREXIA (Fever), CHILLS (Chills) and NAUSEA (Nausea) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 20-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In January 2021, the patient experienced VOMITING (Vomiting), MYALGIA (Body ache), PYREXIA (Fever), CHILLS (Chills), NAUSEA (Nausea), HEADACHE (Headache) and ARTHRALGIA (Joint pain). At the time of the report, VOMITING (Vomiting), MYALGIA (Body ache), NAUSEA (Nausea), HEADACHE (Headache) and ARTHRALGIA (Joint pain) outcome was unknown and PYREXIA (Fever) and CHILLS (Chills) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The patient is a registered nurse who was reporting a "severe reaction to second dose". Concomitant product use was not provided. Approximately 8 hours after the second dose, the patient experienced the above mentioned events.  The patient stated "I thought I was going to die."  On unspecified dates, she tested negative numerous times for COVID-19, including a negative antibody. At the time of the report, 48 hours after the vaccine, the patient still had a low grade fever and chills but said "am feeling better."  Treatment information was not provided.
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Vomiting
Clinical narrative: Vomiting; Body ache; Fever; Chills; Nausea; Headache; Joint pain; This spontaneous case was reported by a nurse and describes the occurrence of VOMITING (Vomiting), MYALGIA (Body ache), PYREXIA (Fever), CHILLS (Chills) and NAUSEA (Nausea) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 20-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In January 2021, the patient experienced VOMITING (Vomiting), MYALGIA (Body ache), PYREXIA (Fever), CHILLS (Chills), NAUSEA (Nausea), HEADACHE (Headache) and ARTHRALGIA (Joint pain). At the time of the report, VOMITING (Vomiting), MYALGIA (Body ache), NAUSEA (Nausea), HEADACHE (Headache) and ARTHRALGIA (Joint pain) outcome was unknown and PYREXIA (Fever) and CHILLS (Chills) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The patient is a registered nurse who was reporting a "severe reaction to second dose". Concomitant product use was not provided. Approximately 8 hours after the second dose, the patient experienced the above mentioned events.  The patient stated "I thought I was going to die."  On unspecified dates, she tested negative numerous times for COVID-19, including a negative antibody. At the time of the report, 48 hours after the vaccine, the patient still had a low grade fever and chills but said "am feeling better."  Treatment information was not provided.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema
Clinical narrative: Had redness on the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (Had redness on the injection site) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Feb-2021, the patient experienced VACCINATION SITE ERYTHEMA (Had redness on the injection site). At the time of the report, VACCINATION SITE ERYTHEMA (Had redness on the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: itching at the injection site; redness at the injection site; swelling at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (itching at the injection site), VACCINATION SITE ERYTHEMA (redness at the injection site) and VACCINATION SITE SWELLING (swelling at the injection site) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (itching at the injection site), VACCINATION SITE ERYTHEMA (redness at the injection site) and VACCINATION SITE SWELLING (swelling at the injection site). The patient was treated with CORTISONE ACETATE at an unspecified dose and frequency and ANTIBIOTICS at an unspecified dose and frequency. At the time of the report, VACCINATION SITE PRURITUS (itching at the injection site), VACCINATION SITE ERYTHEMA (redness at the injection site) and VACCINATION SITE SWELLING (swelling at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Musculoskeletal stiffness, Myalgia
Clinical narrative: Severe headache; Muscle pain; Fatigue; Stiffness in shoulder; Severe chills/was shaking for 4 hours; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULOSKELETAL STIFFNESS (Stiffness in shoulder), CHILLS (Severe chills/was shaking for 4 hours), HEADACHE (Severe headache), MYALGIA (Muscle pain) and FATIGUE (Fatigue) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in November 2020. Concomitant products included RIVAROXABAN (XARELTO) and ATORVASTATIN for an unknown indication.    On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Feb-2021, the patient experienced MUSCULOSKELETAL STIFFNESS (Stiffness in shoulder) and CHILLS (Severe chills/was shaking for 4 hours). On 19-Feb-2021, the patient experienced HEADACHE (Severe headache), MYALGIA (Muscle pain) and FATIGUE (Fatigue). At the time of the report, MUSCULOSKELETAL STIFFNESS (Stiffness in shoulder), CHILLS (Severe chills/was shaking for 4 hours), HEADACHE (Severe headache), MYALGIA (Muscle pain) and FATIGUE (Fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment medications were not provided by reporter.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: Shingles; A spontaneous report was received from a consumer concerning a 79-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events shingles.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 27 Jan 2021, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: 025L20A) intramuscularly in the right arm for prophylaxis of COVID-19 infection.  On 16 Feb 2021, the patient experienced the event(s) shingles.  Treatment details included valacyclovir.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of event(s), shingles was unknown.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Rash macular
Clinical narrative: Red spot; it itched alot; This spontaneous case was reported by a pharmacist and describes the occurrence of RASH MACULAR (Red spot) and PRURITUS (it itched alot) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Jan-2021, the patient experienced RASH MACULAR (Red spot) and PRURITUS (it itched alot). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) on 07-Jan-2021 for Vaccination site reaction, at an unspecified dose and frequency. At the time of the report, RASH MACULAR (Red spot) and PRURITUS (it itched alot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications were not provided by reporter.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Chromaturia, Pain in extremity, Urine odour abnormal
Clinical narrative: left arm hurts; peed with a strange smell and left some pink in the toilet; patient peed with a strange smell; This spontaneous case was reported by a patient family member or friend and describes the occurrence of PAIN IN EXTREMITY (left arm hurts), CHROMATURIA (peed with a strange smell and left some pink in the toilet) and URINE ODOUR ABNORMAL (patient peed with a strange smell) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension, Cholesterol and Hemorrhoids.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, the patient experienced CHROMATURIA (peed with a strange smell and left some pink in the toilet) and URINE ODOUR ABNORMAL (patient peed with a strange smell). On an unknown date, the patient experienced PAIN IN EXTREMITY (left arm hurts). At the time of the report, PAIN IN EXTREMITY (left arm hurts), CHROMATURIA (peed with a strange smell and left some pink in the toilet) and URINE ODOUR ABNORMAL (patient peed with a strange smell) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       concomitant medications included: Blood pressure, cholesterol medication and unspecified medications.  No treatment information was provided.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Asthenia, Decreased appetite, Dizziness, Erythema
Clinical narrative: Arm was red from shoulder to elbow; Weakness; Lost her appetite; Pajamas were wet like she had a fever; Wart in between shoulder and arm; Dizziness; Arm was itching underneath; Joint pain; Little drowsy; This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE (Little drowsy), ERYTHEMA (Arm was red from shoulder to elbow), ASTHENIA (Weakness), DECREASED APPETITE (Lost her appetite) and HYPERHIDROSIS (Pajamas were wet like she had a fever) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 19-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Feb-2021, the patient experienced SOMNOLENCE (Little drowsy), PRURITUS (Arm was itching underneath) and ARTHRALGIA (Joint pain). On 20-Feb-2021, the patient experienced ERYTHEMA (Arm was red from shoulder to elbow), ASTHENIA (Weakness), DECREASED APPETITE (Lost her appetite), HYPERHIDROSIS (Pajamas were wet like she had a fever), SKIN PAPILLOMA (Wart in between shoulder and arm) and DIZZINESS (Dizziness). On 19-Feb-2021, SOMNOLENCE (Little drowsy) had resolved. On 20-Feb-2021, HYPERHIDROSIS (Pajamas were wet like she had a fever) had resolved. On 21-Feb-2021, DECREASED APPETITE (Lost her appetite) had resolved. At the time of the report, ERYTHEMA (Arm was red from shoulder to elbow), ASTHENIA (Weakness), SKIN PAPILLOMA (Wart in between shoulder and arm), DIZZINESS (Dizziness), PRURITUS (Arm was itching underneath) and ARTHRALGIA (Joint pain) outcome was unknown.            Treatment and concomitant medications were not provided by reporter.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Hyperhidrosis, Pruritus, Skin papilloma, Somnolence
Clinical narrative: Arm was red from shoulder to elbow; Weakness; Lost her appetite; Pajamas were wet like she had a fever; Wart in between shoulder and arm; Dizziness; Arm was itching underneath; Joint pain; Little drowsy; This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE (Little drowsy), ERYTHEMA (Arm was red from shoulder to elbow), ASTHENIA (Weakness), DECREASED APPETITE (Lost her appetite) and HYPERHIDROSIS (Pajamas were wet like she had a fever) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 19-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Feb-2021, the patient experienced SOMNOLENCE (Little drowsy), PRURITUS (Arm was itching underneath) and ARTHRALGIA (Joint pain). On 20-Feb-2021, the patient experienced ERYTHEMA (Arm was red from shoulder to elbow), ASTHENIA (Weakness), DECREASED APPETITE (Lost her appetite), HYPERHIDROSIS (Pajamas were wet like she had a fever), SKIN PAPILLOMA (Wart in between shoulder and arm) and DIZZINESS (Dizziness). On 19-Feb-2021, SOMNOLENCE (Little drowsy) had resolved. On 20-Feb-2021, HYPERHIDROSIS (Pajamas were wet like she had a fever) had resolved. On 21-Feb-2021, DECREASED APPETITE (Lost her appetite) had resolved. At the time of the report, ERYTHEMA (Arm was red from shoulder to elbow), ASTHENIA (Weakness), SKIN PAPILLOMA (Wart in between shoulder and arm), DIZZINESS (Dizziness), PRURITUS (Arm was itching underneath) and ARTHRALGIA (Joint pain) outcome was unknown.            Treatment and concomitant medications were not provided by reporter.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Slightly sore arm 24 hours after getting the vaccine; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Slightly sore arm 24 hours after getting the vaccine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced VACCINATION SITE PAIN (Slightly sore arm 24 hours after getting the vaccine). At the time of the report, VACCINATION SITE PAIN (Slightly sore arm 24 hours after getting the vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The concomitant medications and treatment details were not provided.   Most recent FOLLOW-UP information incorporated above includes: On 15-Apr-2021: Follow-up information received on 15-Apr-2021 included email ID,  onset latency of the event slightly sore arm 24 hours after getting the vaccine.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Vaccination site bruising, Vaccination site erythema, Vaccination site mass, Vaccination site swelling
Clinical narrative: red bump; headache; Red; little bruise; swelled; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE BRUISING (little bruise), VACCINATION SITE MASS (red bump), HEADACHE (headache), VACCINATION SITE SWELLING (swelled) and VACCINATION SITE ERYTHEMA (Red) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. U06M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Feb-2021, the patient experienced VACCINATION SITE BRUISING (little bruise) and VACCINATION SITE SWELLING (swelled). On 21-Feb-2021, the patient experienced VACCINATION SITE MASS (red bump), HEADACHE (headache) and VACCINATION SITE ERYTHEMA (Red). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form and BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE, PRAMOCAINE HYDROCHLORIDE (NEOSPORIN + BURN RELIEF) at a dose of 1 dosage form. At the time of the report, VACCINATION SITE BRUISING (little bruise), VACCINATION SITE MASS (red bump), HEADACHE (headache), VACCINATION SITE SWELLING (swelled) and VACCINATION SITE ERYTHEMA (Red) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not provided by reporter.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Muscle spasms
Clinical narrative: Muscle Spasms; Really exhausted; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Really exhausted) and MUSCLE SPASMS (Muscle Spasms) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Feb-2021, the patient experienced FATIGUE (Really exhausted). On 20-Feb-2021, the patient experienced MUSCLE SPASMS (Muscle Spasms). On 20-Feb-2021, MUSCLE SPASMS (Muscle Spasms) had resolved. At the time of the report, FATIGUE (Really exhausted) outcome was unknown.            Treatment and concomitant medications were not provided by reporter.   Reporter did not allow further contact
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Decreased appetite, Dizziness, Feeling cold, Headache
Clinical narrative: Hives all over the body; Itchy all over the body; Stayed in bed for 3 days; Fever; Headache; Vomits; Does not want to eat, does not have appetite; Is not able to sleep; Intense pain in the arm, from the thumb to the ears; Intense cold; Felt very dizzy; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Intense pain in the arm, from the thumb to the ears), FEELING COLD (Intense cold), DIZZINESS (Felt very dizzy), URTICARIA (Hives all over the body) and DECREASED APPETITE (Does not want to eat, does not have appetite) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History was provided by the reporter.  Concurrent medical conditions included Asthma, Allergy to animal (Allergic to cats, dogs), Allergy (Allergy to pines) and Dust allergy. Concomitant products included FLUTICASONE PROPIONATE (FLOVENT) for Asthma, IBANDRONATE SODIUM (BONIVA), VITAMINS NOS, MAGNESIUM, POTASSIUM, FOLIC ACID and CALCIUM CITRATE, COLECALCIFEROL (CITRACAL + D3) for an unknown indication.    On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On 15-Feb-2021, the patient experienced PAIN IN EXTREMITY (Intense pain in the arm, from the thumb to the ears), FEELING COLD (Intense cold), DIZZINESS (Felt very dizzy), DECREASED APPETITE (Does not want to eat, does not have appetite), INSOMNIA (Is not able to sleep), ILLNESS (Stayed in bed for 3 days), PYREXIA (Fever), HEADACHE (Headache) and VOMITING (Vomits).    On 16-Feb-2021, the patient experienced URTICARIA (Hives all over the body) and PRURITUS (Itchy all over the body). The patient was treated with IBUPROFEN (oral) on 15-Feb-2021 for Hives, at a dose of 1 dosage form; CLARITHROMYCIN (CLARITIN [CLARITHROMYCIN]) (oral) on 15-Feb-2021 for Hives, at an unspecified dose and frequency and PARACETAMOL (TYLENOL) on 15-Feb-2021 for Hives, at an unspecified dose and frequency.  On 15-Feb-2021, VOMITING (Vomits) had resolved.   On 17-Feb-2021, PAIN IN EXTREMITY (Intense pain in the arm, from the thumb to the ears), FEELING COLD (Intense cold), DIZZINESS (Felt very dizzy), URTICARIA (Hives all over the body), ILLNESS (Stayed in bed for 3 days), PYREXIA (Fever) and HEADACHE (Headache) had resolved.   At the time of the report, DECREASED APPETITE (Does not want to eat, does not have appetite), INSOMNIA (Is not able to sleep) and PRURITUS (Itchy all over the body) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 15-Feb-2021, Body temperature: 102 (High) Patient had fever of 102 F. On 16-Feb-2021, Body temperature: 101 (High) Patient had fever of 101°F..   The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Most recent FOLLOW-UP information incorporated above includes: On 27-Apr-2021
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Illness, Insomnia, Pain in extremity, Pruritus, Pyrexia
Clinical narrative: Hives all over the body; Itchy all over the body; Stayed in bed for 3 days; Fever; Headache; Vomits; Does not want to eat, does not have appetite; Is not able to sleep; Intense pain in the arm, from the thumb to the ears; Intense cold; Felt very dizzy; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Intense pain in the arm, from the thumb to the ears), FEELING COLD (Intense cold), DIZZINESS (Felt very dizzy), URTICARIA (Hives all over the body) and DECREASED APPETITE (Does not want to eat, does not have appetite) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History was provided by the reporter.  Concurrent medical conditions included Asthma, Allergy to animal (Allergic to cats, dogs), Allergy (Allergy to pines) and Dust allergy. Concomitant products included FLUTICASONE PROPIONATE (FLOVENT) for Asthma, IBANDRONATE SODIUM (BONIVA), VITAMINS NOS, MAGNESIUM, POTASSIUM, FOLIC ACID and CALCIUM CITRATE, COLECALCIFEROL (CITRACAL + D3) for an unknown indication.    On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On 15-Feb-2021, the patient experienced PAIN IN EXTREMITY (Intense pain in the arm, from the thumb to the ears), FEELING COLD (Intense cold), DIZZINESS (Felt very dizzy), DECREASED APPETITE (Does not want to eat, does not have appetite), INSOMNIA (Is not able to sleep), ILLNESS (Stayed in bed for 3 days), PYREXIA (Fever), HEADACHE (Headache) and VOMITING (Vomits).    On 16-Feb-2021, the patient experienced URTICARIA (Hives all over the body) and PRURITUS (Itchy all over the body). The patient was treated with IBUPROFEN (oral) on 15-Feb-2021 for Hives, at a dose of 1 dosage form; CLARITHROMYCIN (CLARITIN [CLARITHROMYCIN]) (oral) on 15-Feb-2021 for Hives, at an unspecified dose and frequency and PARACETAMOL (TYLENOL) on 15-Feb-2021 for Hives, at an unspecified dose and frequency.  On 15-Feb-2021, VOMITING (Vomits) had resolved.   On 17-Feb-2021, PAIN IN EXTREMITY (Intense pain in the arm, from the thumb to the ears), FEELING COLD (Intense cold), DIZZINESS (Felt very dizzy), URTICARIA (Hives all over the body), ILLNESS (Stayed in bed for 3 days), PYREXIA (Fever) and HEADACHE (Headache) had resolved.   At the time of the report, DECREASED APPETITE (Does not want to eat, does not have appetite), INSOMNIA (Is not able to sleep) and PRURITUS (Itchy all over the body) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 15-Feb-2021, Body temperature: 102 (High) Patient had fever of 102 F. On 16-Feb-2021, Body temperature: 101 (High) Patient had fever of 101°F..   The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Most recent FOLLOW-UP information incorporated above includes: On 27-Apr-2021
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Urticaria, Vomiting
Clinical narrative: Hives all over the body; Itchy all over the body; Stayed in bed for 3 days; Fever; Headache; Vomits; Does not want to eat, does not have appetite; Is not able to sleep; Intense pain in the arm, from the thumb to the ears; Intense cold; Felt very dizzy; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Intense pain in the arm, from the thumb to the ears), FEELING COLD (Intense cold), DIZZINESS (Felt very dizzy), URTICARIA (Hives all over the body) and DECREASED APPETITE (Does not want to eat, does not have appetite) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History was provided by the reporter.  Concurrent medical conditions included Asthma, Allergy to animal (Allergic to cats, dogs), Allergy (Allergy to pines) and Dust allergy. Concomitant products included FLUTICASONE PROPIONATE (FLOVENT) for Asthma, IBANDRONATE SODIUM (BONIVA), VITAMINS NOS, MAGNESIUM, POTASSIUM, FOLIC ACID and CALCIUM CITRATE, COLECALCIFEROL (CITRACAL + D3) for an unknown indication.    On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On 15-Feb-2021, the patient experienced PAIN IN EXTREMITY (Intense pain in the arm, from the thumb to the ears), FEELING COLD (Intense cold), DIZZINESS (Felt very dizzy), DECREASED APPETITE (Does not want to eat, does not have appetite), INSOMNIA (Is not able to sleep), ILLNESS (Stayed in bed for 3 days), PYREXIA (Fever), HEADACHE (Headache) and VOMITING (Vomits).    On 16-Feb-2021, the patient experienced URTICARIA (Hives all over the body) and PRURITUS (Itchy all over the body). The patient was treated with IBUPROFEN (oral) on 15-Feb-2021 for Hives, at a dose of 1 dosage form; CLARITHROMYCIN (CLARITIN [CLARITHROMYCIN]) (oral) on 15-Feb-2021 for Hives, at an unspecified dose and frequency and PARACETAMOL (TYLENOL) on 15-Feb-2021 for Hives, at an unspecified dose and frequency.  On 15-Feb-2021, VOMITING (Vomits) had resolved.   On 17-Feb-2021, PAIN IN EXTREMITY (Intense pain in the arm, from the thumb to the ears), FEELING COLD (Intense cold), DIZZINESS (Felt very dizzy), URTICARIA (Hives all over the body), ILLNESS (Stayed in bed for 3 days), PYREXIA (Fever) and HEADACHE (Headache) had resolved.   At the time of the report, DECREASED APPETITE (Does not want to eat, does not have appetite), INSOMNIA (Is not able to sleep) and PRURITUS (Itchy all over the body) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 15-Feb-2021, Body temperature: 102 (High) Patient had fever of 102 F. On 16-Feb-2021, Body temperature: 101 (High) Patient had fever of 101°F..   The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Most recent FOLLOW-UP information incorporated above includes: On 27-Apr-2021
Age: 90.0
Sex: F
Vaccine: COVID19
Symptoms: Decreased appetite, Pain in extremity
Clinical narrative: loss of appetite; arm pain; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm pain) and DECREASED APPETITE (loss of appetite) in a 90-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes. Concomitant products included CARBOHYDRATES NOS, CHOLESTEROL, FATS NOS, MINERALS NOS, POTASSIUM, PROTEIN, SODIUM, VITAMINS NOS (GLUCERNA ADVANCE) for Diabetes mellitus.    On 09-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Feb-2021, the patient experienced PAIN IN EXTREMITY (arm pain). On 16-Feb-2021, the patient experienced DECREASED APPETITE (loss of appetite). On 10-Feb-2021, PAIN IN EXTREMITY (arm pain) had resolved. At the time of the report, DECREASED APPETITE (loss of appetite) outcome was unknown.            Treatment medications were not provided by reporter.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Nausea, Vertigo
Clinical narrative: vertigo; dizziness; nausea; This spontaneous case was reported by a consumer and describes the occurrence of VERTIGO (vertigo), DIZZINESS (dizziness) and NAUSEA (nausea) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013L20A and 026L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 16-Feb-2021, the patient experienced VERTIGO (vertigo), DIZZINESS (dizziness) and NAUSEA (nausea). On 17-Feb-2021, VERTIGO (vertigo), DIZZINESS (dizziness) and NAUSEA (nausea) had resolved.            Treatment and concomitant medications were not provided by reporter.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: started itching at the injection site and around it; soreness at the injection site; swollen; redness; tenderness,if she lay down her arm it is tender; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (soreness at the injection site), VACCINATION SITE SWELLING (swollen), VACCINATION SITE ERYTHEMA (redness), VACCINATION SITE PAIN (tenderness,if she lay down her arm it is tender) and VACCINATION SITE PRURITUS (started itching at the injection site and around it) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination.     The patient's past medical history included Osteoporosis, Hypertension, Renal disease, Vitamin D deficiency, Chronic back pain, Lumbosacral (joint) (ligament) sprain and Constipation. Concomitant products included AMLODIPINE for Hypertension, METOPROLOL and CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000) for an unknown indication.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Feb-2021, the patient experienced VACCINATION SITE PAIN (soreness at the injection site), VACCINATION SITE SWELLING (swollen), VACCINATION SITE ERYTHEMA (redness) and VACCINATION SITE PAIN (tenderness,if she lay down her arm it is tender). On an unknown date, the patient experienced VACCINATION SITE PRURITUS (started itching at the injection site and around it). At the time of the report, VACCINATION SITE PAIN (soreness at the injection site), VACCINATION SITE SWELLING (swollen), VACCINATION SITE ERYTHEMA (redness), VACCINATION SITE PAIN (tenderness,if she lay down her arm it is tender) and VACCINATION SITE PRURITUS (started itching at the injection site and around it) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment medication included white alcohol.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Vaccination site erythema, Vaccination site swelling, Vaccination site warmth
Clinical narrative: Swelling; a little warm beneath; redness; The arm is a little sore; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (Swelling), VACCINATION SITE ERYTHEMA (redness), VACCINATION SITE WARMTH (a little warm beneath) and PAIN IN EXTREMITY (The arm is a little sore) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination.     The patient's past medical history included Stroke in 2003, Colitis, Osteoporosis, Cholesterol and Heart disease, unspecified.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Feb-2021, the patient experienced PAIN IN EXTREMITY (The arm is a little sore). On 12-Feb-2021, the patient experienced VACCINATION SITE ERYTHEMA (redness). On an unknown date, the patient experienced VACCINATION SITE SWELLING (Swelling) and VACCINATION SITE WARMTH (a little warm beneath). At the time of the report, VACCINATION SITE SWELLING (Swelling), VACCINATION SITE ERYTHEMA (redness), VACCINATION SITE WARMTH (a little warm beneath) and PAIN IN EXTREMITY (The arm is a little sore) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment medications were not provided by reporter. Concomitant medications reported were colitis medications,osteoporosis medications,cholesterol med,and heart medications.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: mild arm soreness; This spontaneous case was reported by a consumer and describes the occurrence of   in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 020L20A) for COVID-19 vaccination.     no medical history was provided by the reporter.  Concomitant products included ATORVASTATIN for Cholesterol, LISINOPRIL for Hypertension, LEVOTHYROXINE for Parathyroid tumour.   On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       treatment medication: tylenol   Most recent FOLLOW-UP information incorporated above includes: On 28-Apr-2021: Caller returning call from Safety, concomitant  medication was updated
Sex: M
Vaccine: COVID19
Symptoms: Chills, Pain in extremity
Clinical narrative: Sore arm; Chills; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm) and CHILLS (Chills) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore arm) and CHILLS (Chills). At the time of the report, PAIN IN EXTREMITY (Sore arm) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was not provided.
Age: 90.0
Sex: F
Vaccine: COVID19
Symptoms: Hyperhidrosis, Injection site rash, Pruritus
Clinical narrative: rash at the site of injection; her arm started to itch; excessive sweat across stomach area; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE RASH (rash at the site of injection), PRURITUS (her arm started to itch) and HYPERHIDROSIS (excessive sweat across stomach area) in a 90-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INJECTION SITE RASH (rash at the site of injection), PRURITUS (her arm started to itch) and HYPERHIDROSIS (excessive sweat across stomach area). At the time of the report, INJECTION SITE RASH (rash at the site of injection), PRURITUS (her arm started to itch) and HYPERHIDROSIS (excessive sweat across stomach area) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment and concomitant medications were not provided by reporter.